A technology that diagnoses various diseases, including Alzheimer’s and Parkinson’s, using just a few drops of blood from a finger prick is called “blood biomarker measurement.” In recent years, ...

Alzheimer’s disease biomarkers measured from finger-prick dried blood samples closely match standard plasma tests and predict CSF pathology with good accuracy, a large-scale study shows.

Researchers found that blood samples collected at home and mailed in can reliably track early Alzheimer’s-related brain ...

Dried blood spot technology may make biomarker testing more accessible ...

The development of blood-based biomarkers for Alzheimer’s disease has fueled progress for both research and clinical translation. Now scientists want to do the same for other neurodegenerative ...

Indias first AI-integrated blood biomarker test with PET and MRI imaging shows promises with early Alzheimers detection, safer diagnosis and timely care planning.

In the “omics” era, where bigger is better, the Global Neurodegeneration Proteomics Consortium is making a splash. To date, this two-year-old initiative led by Gates Ventures and Johnson & Johnson has ...

In this study, researchers aimed to determine whether ctDNA is detectable in other bodily fluids besides blood, and to characterize any ctDNA they were able to detect.